On Nov. 18, 2015 Thermo Fisher Scientific Inc., a life sciences research company, announced the opening of their new GMP clinical services facility in Singapore. This new facility is meant to help meet the growing demand for clinical supply services in the region.
According to a press release from the company, Thermo Fisher Scientific Inc. opened its first clinical services facility in Singapore in 2001. The new facility will be located on Toh Guan Road, Jurong East and is nearly 70,000 ft2-60% larger than the previous site. The new site will provide pharmaceutical and biotech companies with clinical supplies including GMP storage, local labeling, secondary packaging, comparator sourcing, handling, and distribution of ambient and cold chain supplies.
Leon Wyszkowski, Thermo Fisher’s vice-president of Clinical Services for North America and facility network, says Singapore is the company’s fastest growing market and contributor to their growth. According to the company, clinical trial studies conducted in emerging Asian markets have increased in the past ten years, as a result of lower study costs and large patient populations.
Source: Thermo Fisher Scientific
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.